Alprostadil

Overview

Alprostadil is the synthetic, pharmaceutical form of prostaglandin E1 (PGE1), a naturally occurring lipid mediator derived from the omega-6 fatty acid dihomo-gamma-linolenic acid. It is among the oldest and most thoroughly investigated vasoactive compounds in clinical research, with continuous study since the 1970s.

Unlike peptide hormones such as angiotensin-II or adrenomedullin, alprostadil belongs to the eicosanoid class — small lipid signaling molecules formed from arachidonic-acid-family precursors. It plays endogenous roles in vasodilation, platelet inhibition, and smooth muscle relaxation, and has been adapted into several clinical and investigational preparations.

Alprostadil is most widely recognized in research contexts for its role in erectile physiology, peripheral vascular disease investigation, and neonatology. It is typically studied as an intracavernosal injection, intraurethral suppository, or intravenous infusion, depending on the model.

Structure / Chemistry

Alprostadil is chemically identical to endogenous prostaglandin E1:

• IUPAC class: 20-carbon cyclopentane-containing eicosanoid
• Molecular formula: C20H34O5
• Molecular weight: 354.48 g/mol
• Key features: cyclopentanone ring with hydroxyl and alpha-keto functionality, two side chains bearing a terminal carboxylic acid and secondary hydroxyl

PGE1 is distinguished from other E-series prostaglandins (PGE2, PGE3) by the number and location of double bonds in its alpha and omega side chains. It is relatively unstable in aqueous solution and is typically formulated with alpha-cyclodextrin or lyophilized with lactose for stability.

Mechanism of Action

Alprostadil acts primarily through G-protein-coupled EP receptors (EP1, EP2, EP3, EP4) on vascular smooth muscle, platelets, and cavernosal tissue. The predominant downstream effects include:

• Gs-mediated adenylyl cyclase activation via EP2 and EP4, raising intracellular cyclic AMP (cAMP)
• Smooth muscle relaxation in corpus cavernosum and peripheral arterioles, producing vasodilation
• Platelet aggregation inhibition through elevated cAMP in platelets
• Ductus arteriosus patency maintenance through EP4-driven smooth muscle relaxation in neonatal ductal tissue

In erectile function research, elevated cAMP reduces intracellular calcium in cavernosal smooth muscle, allowing relaxation, sinusoidal filling, and venous occlusion — the hemodynamic basis of erection. The mechanism is complementary to nitric-oxide-driven cGMP pathways targeted by PDE5 inhibitors.

Research Summary

Research in peripheral ischemia, Raynaud phenomenon, and pulmonary hypertension is ongoing, though results have been mixed.

Pharmacokinetics

Alprostadil is rapidly cleared from circulation, with roughly 60–80% of a dose metabolized in a single pulmonary pass via beta-oxidation and 15-hydroxyprostaglandin dehydrogenase. Plasma half-life is estimated at 30 seconds to a few minutes, which is why it is administered locally (intracavernosal, intraurethral) or as a continuous infusion in neonatal and vascular applications.

Metabolites are excreted predominantly in urine over 24 hours. Local cavernosal injection concentrates pharmacologic effect in target tissue while minimizing systemic exposure. The compound does not cross cell membranes in the manner of steroid hormones; its effects are receptor-mediated at the cell surface.

Common Discussion Topics

• Comparison with PDE5 inhibitors and combination approaches in erectile research
• Injection-site discomfort and penile pain as commonly reported adverse effects
• Use of alpha-cyclodextrin-stabilized vs lyophilized formulations
• Role in neonatal ductus arteriosus management and pre-surgical stabilization
• Investigational roles in peripheral artery disease, scleroderma, and frostbite

Related Compounds

• Adrenomedullin — peptide vasodilator with overlapping hemodynamic effects
• Angiotensin-1-7 — counter-regulatory vascular peptide
• BPC-157 — researched for angiogenic and vascular-healing activity
• Bradykinin — endogenous vasodilator peptide
• Icatibant — bradykinin B2 antagonist, contrasting vascular pharmacology

Educational information only. Alprostadil is a prescription medication in many jurisdictions and is not intended for self-administration. This article does not provide medical advice or dosing guidance.